Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2023-05-23 00:00:00 ET · period of report 2023-05-19 · accession 0001801385-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-23 | 2023-05-19+ | KRYS | Romano Kathryn | CAO | M - OptEx | $55.08 | +50.0K | 15.5K | New | +$2.75M |
| DM | 2023-05-23 | 2023-05-19+ | KRYS | Romano Kathryn | CAO | S - Sale+OE | $101.60 | -53.4K | 12.6K | -81% | -$5.43M |
| DM | 2023-05-23 | 2023-05-19+ | KRYS | Romano Kathryn | CAO | M - OptEx | $0.00 | -50.0K | 37.5K | -57% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-22 | M | A | 2,521 | $52.26 | 15,077 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-22 | S | D | 12,500 | $110.00 | 12,556 | D | — | — | (F11) The transaction was executed in a single trade. |
| 3 | Common | Common Stock | 2023-05-22 | M | A | 12,500 | $63.55 | 25,056 | D | — | — | |
| 4 | Common | Common Stock | 2023-05-22 | S | D | 3,154 | $109.99 | 12,556 | D | — | — | (F9) The transaction was executed in multiple trades ranging from $109.9700 to $110.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Common | Common Stock | 2023-05-22 | M | A | 3,154 | $52.26 | 15,710 | D | — | — | |
| 6 | Common | Common Stock | 2023-05-19 | M | A | 12,500 | $52.26 | 28,484 | D | — | — | |
| 7 | Common | Common Stock | 2023-05-19 | S | D | 12,500 | $95.05 | 15,984 | D | — | — | (F2) The transaction was executed in multiple trades ranging from $95.0000 to $95.3800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 8 | Common | Common Stock | 2023-05-19 | M | A | 12,500 | $52.26 | 28,484 | D | — | — | |
| 9 | Common | Common Stock | 2023-05-19 | S | D | 12,500 | $95.04 | 15,984 | D | — | — | (F2) The transaction was executed in multiple trades ranging from $95.0000 to $95.3800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 10 | Common | Common Stock | 2023-05-19 | S | D | 3,428 | $95.08 | 12,556 | D | — | — | (F2) The transaction was executed in multiple trades ranging from $95.0000 to $95.3800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 11 | Common | Common Stock | 2023-05-22 | S | D | 2,521 | $105.80 | 12,556 | D | — | — | (F5) The transaction was executed in multiple trades ranging from $105.3400 to $106.3100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 12 | Common | Common Stock | 2023-05-22 | M | A | 2,570 | $52.26 | 15,126 | D | — | — | |
| 13 | Common | Common Stock | 2023-05-22 | S | D | 2,570 | $106.81 | 12,556 | D | — | — | (F6) The transaction was executed in multiple trades ranging from $106.3700 to $107.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 14 | Common | Common Stock | 2023-05-22 | M | A | 1,300 | $52.26 | 13,856 | D | — | — | |
| 15 | Common | Common Stock | 2023-05-22 | S | D | 1,300 | $107.88 | 12,556 | D | — | — | (F7) The transaction was executed in multiple trades ranging from $107.6900 to $108.4200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 16 | Common | Common Stock | 2023-05-22 | M | A | 2,955 | $52.26 | 15,511 | D | — | — | |
| 17 | Common | Common Stock | 2023-05-22 | S | D | 2,955 | $109.17 | 12,556 | D | — | — | (F8) The transaction was executed in multiple trades ranging from $108.9000 to $109.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 18 | Derivative | Stock Option (Right to Buy) | 2023-05-22 | M | D | 12,500 | $0.00 | 12,500 | D | $52.26 · — to 2030-01-30 | 12,500 Common Stock | (F12) 50,000 options were granted that vest in four equal annual installments beginning on January 21, 2021. |
| 19 | Derivative | Stock Option (Right to Buy) | 2023-05-19 | M | D | 12,500 | $0.00 | 25,000 | D | $52.26 · — to 2030-01-30 | 12,500 Common Stock | (F12) 50,000 options were granted that vest in four equal annual installments beginning on January 21, 2021. |
| 20 | Derivative | Stock Option (Right to Buy) | 2023-05-19 | M | D | 12,500 | $0.00 | 37,500 | D | $52.26 · — to 2030-01-30 | 12,500 Common Stock | (F12) 50,000 options were granted that vest in four equal annual installments beginning on January 21, 2021. |
| 21 | Derivative | Stock Option (Right to Buy) | 2023-05-22 | M | D | 12,500 | $0.00 | 37,500 | D | $63.55 · — to 2032-02-27 | 12,500 Common Stock | (F13) 50,000 options were granted that vest in four equal annual installments beginning on February 28, 2023. |